[1] Saeedi G, Jeivad F, Goharbari M, et al. Ethanol extract of crataegus oxyacantha l ameliorate dietary non-alcoholic fatty liver disease in rat. Drug Res (Stuttg), 2018, 33(7): 345-349. [2] Zierau O, Helle J, Schadyew S, et al. Role of miR-203 in estrogen receptor-mediated signaling in the rat uterus and endometrial carcinoma. J Cell Biochem, 2018, 119(7): 5359-5372. [3] Boll K, Reiche K, Kasack K, et al. miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Oncogene, 2013, 32(3): 277-285. [4] Zarzour RHA, Alshawsh MA, Asif M, et al. Adipocytokineregulation and antiangiogenic activity underlie the molecular mechanisms of therapeutic effects of phyllanthus niruri against non-alcoholic fatty liver disease. Nutrients, 2018, 10(8): 23-27. [5] 王洪岩,迟程,徐有青,等.小檗碱对酒精性肝炎小鼠“肠漏”的保护作用.实用肝脏病杂志,2017,20(6):663-667. [6] Tripathi AK, Dwivedi A, Pal MK, et al. Attenuated neuroprotective effect of riboflavin under UV-B irradiation via miR-203/c-Jun signaling pathway in vivo and in vitro. J Biomed Sci, 2014, 21(3): 39-40. [7] Zheng XB, Chen XB, Xu LL, et al. miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liver. Cancer Sci, 2017, 108(3): 338-346. [8] Yang L, Engeland CG, Cheng B. Social isolation impairs oral palatal wound healing in sprague-dawley rats: a role for miR-29 and miR-203 via VEGF suppression. PLoS One, 2013, 8(8): 723-725. [9] Lu YW, Zhu YC, Zhang L, et al. Ilexgenin A enhances the effects of simvastatin on non-alcoholic fatty liver disease without changes in simvastatin pharmacokinetics. Chin J Nat Med, 2018, 16(6): 436-445. [10] 王洪岩,李鑫,徐有青. 酒精性肝病发病机制研究进展. 实用肝脏病杂志,2014,17 (1) : 5-6. [11] Su B, Jia Y, Hong J, et al. Sodiumbutyrate ameliorates high-fat-diet-induced non-alcoholic fatty liver disease through peroxisome proliferator-activated receptor alpha-mediated activation of beta oxidation and suppression of inflammation. J Agric Food Chem, 2018, 66(29): 7633-7642. [12] Zhao MG, Sheng XP,Huang YP, et al. Triterpenic acids-enriched fraction from cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction. Biomed Pharmacother, 2018, 104(5), 229-239. [13] Uchiyama T, Ota H, Itaya-Hironaka A, et al. Up-regulation of selenoprotein P and HIP/PAP mRNAs in hepatocytes by intermittent hypoxia via down-regulation of miR-203. Biochem Biophys Rep, 2017, 11(2): 130-137. [14] Su P, Zhao F, Cao Z, et al. Mir-203-mediated tricellulin mediates lead-induced in vitro loss of blood-cerebrospinal fluid barrier (BCB) function. Toxicol In Vitro, 2015, 29(5): 1185-1194. [15] Li H, Huang Y, Ma C, et al. MiR-203 involves in neuropathic pain development and represses Rap1a expression in nerve growth factor differentiated neuronal PC12 cells. Clin J Pain, 2018,31(1): 36-43. [16] Zhang Y, Wang C, Yu B, et al. Gastrodin protects against ethanol-induced liver injury and apoptosis in HepG2 cells and animal models of alcoholic liver disease. Biol Pharm Bull, 2018, 41(5): 670-679. [17] Zhou J,Huang H,Tong S, et al. Overexpression of long non-coding RNA cancer susceptibility 2 inhibits cell invasion and angiogenesis in gastric cancer. Mol Med Rep,2017,16(4):5235-5240. [18] Liang Y, Lin C, Zhang Y, et al. Probiotic mixture oflactobacillus and bifidobacterium alleviates systemic adiposity and inflammation in non-alcoholic fatty liver disease rats through Gpr109a and the commensal metabolite butyrate. Inflammopharmacology, 2018, 26(4): 1051-1055. [19] Yao H, Tao X, Xu L, et al. Dioscin alleviates non-alcoholic fatty liver disease through adjusting lipid metabolism via SIRT1/AMPK signaling pathway. Pharmacol Res, 2018, 131(9): 51-60. [20] Christensen CU, Glavind E, Thomsen KL, et al. Niemann-Pick type C2 protein supplementation in experimental non-alcoholic fatty liver disease. PLoS One, 2018, 13(3): 192-208. |